Search Results 1291-1300 of 11396 for anti-TNF drugs

  1. Physical Medicine and Rehabilitation Physicians - Medical Professionals - Mayo Clinic

    Diseases & Conditions · Symptoms · Tests & Procedures · Drugs & Supplements · Healthy Lifestyle · Mayo Clinic Health Letter & Books · Mayo Clinic Health Letter ...

  2. Daxibotulinumtoxina-lanm (intramuscular route) - Side effects & uses - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  3. Clinical trials - Oncology (Medical)

    ... treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti ...

  4. Eladocagene exuparvovec-tneq (injection route) - Side effects & uses - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  5. Clinical trials - Oncology (Medical)

    This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) ...

  6. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  7. Sodium tetradecyl sulfate (intravenous route) - Side effects & uses - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  8. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  9. A Pilot Study To Assess The Efficacy Of Rituximab Therapy In Treatment Resistant FSGS - Mayo Clinic

    The purpose of this study is to determine whether Rituximab therapy is safe and effective in treating patients with the kidney condition, focal segmental ...

  10. Immune Predictors Of Response To Pembrolizumab Therapy In Stage IV Melanoma Patients - Mayo Clinic

    About this study. This study will test whether immune functions in individual cancer patients can be characterized in a quantitative manner using new ...